A PYMNTS Company
Antitrust Chronicle<sup>®</sup> – Killer Acquisitions

Antitrust Chronicle® – Killer Acquisitions

Spring 2020, Volume 2, Number 2

Dear Readers, What is a killer acquisition? The term was first employed in the pharmaceutical sector to describe acquisitions by an incumbent of a competitor that threatened to launch a blockbuster drug that would undermine its own products, with a view to shutting it down. In recent times, the term…

Read More

In this issue

Antitrust Chronicle® – Killer Acquisitions
 - May 26, 2020
“Killer Acquisitions,” Big Tech, and Section 2: A Solution in Search of a Problem
 - May 26, 2020
“How Tech Rolls”: Potential Competition and “Reverse” Killer Acquisitions
 - May 26, 2020
The No Kill Zone: The Other Side of Pharma Acquisitions
 - May 26, 2020
Beyond Killer Acquisitions: Are There More Common Potential Competition Issues in Tech Deals and How Can These Be Assessed?
 - May 26, 2020
Remember Stacker? Another Look at “Killer” Acquisitions in the Digital Economy
 - May 26, 2020
The Jury Is Out: An Assessment of Proposed Reforms to Australia’s Merger Control Regime for Addressing Competitive Harm in the (Digital) Economy
 - May 26, 2020
Assessing “Killer Acquisitions”: An Assets and Capabilities-Based View of the Start-Up
 - May 26, 2020

In case you missed it...



April 2024


March 2024


February 2024
See more Chronicles by year:

Featured News

Google and South Carolina Clash Over State Records Demand
May 8, 2024 by

Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by

Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by

Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by

EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by